The Traderszone Network

Published in TZ Latest News 28 November, 2015 by The TZ Newswire Staff

Amgen Inc. Takes Aim at AbbVie Inc.

Amgen has filed an application for approval of its biosimilar to AbbVie’s top-selling Humira.